milrinone has been researched along with Hypertension, Portal in 1 studies
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couture, EJ | 1 |
| Tremblay, JA | 1 |
| Elmi-Sarabi, M | 1 |
| Lamarche, Y | 1 |
| Denault, AY | 1 |
1 other study available for milrinone and Hypertension, Portal
| Article | Year |
|---|---|
Noninvasive Administration of Inhaled Epoprostenol and Inhaled Milrinone in Extubated, Spontaneously Breathing Patients With Right Ventricular Failure and Portal Hypertension: A Report of 2 Cases.
Topics: Administration, Inhalation; Aged; Airway Extubation; Antihypertensive Agents; Cardiac Surgical Proce | 2019 |